Display options
Cite
Sharieh Hosseini SG, Khatamsaz S, Shariati M. The effects of losartan on memory performance and leptin resistance induced by obesity and high-fat diet in adult male rats. Iran J Basic Med Sci. 2014;17(1):41-8
Sharieh Hosseini, S. G., Khatamsaz, S., & Shariati, M. (2014). The effects of losartan on memory performance and leptin resistance induced by obesity and high-fat diet in adult male rats. Iranian journal of basic medical sciences, 17(1), 41-8.
Sharieh Hosseini, Seyydeh Gohar, et al. "The effects of losartan on memory performance and leptin resistance induced by obesity and high-fat diet in adult male rats." Iranian journal of basic medical sciences vol. 17,1 (2014): 41-8.
Sharieh Hosseini SG, Khatamsaz S, Shariati M. The effects of losartan on memory performance and leptin resistance induced by obesity and high-fat diet in adult male rats. Iran J Basic Med Sci. 2014 Jan;17(1):41-8. PMID: 24592306; PMCID: PMC3938885.
Copy Download .nbib Format: NLM
Share it on

Iran J Basic Med Sci. 2014 Jan;17(1):41-8.

The effects of losartan on memory performance and leptin resistance induced by obesity and high-fat diet in adult male rats.

Iranian journal of basic medical sciences

Seyydeh Gohar Sharieh Hosseini, Saeed Khatamsaz, Mehrdad Shariati

Affiliations

  1. Islamic Azad University, Kazerun Branch, Department of Physiology, Kazerun, Iran.
  2. Islamic Azad University, Zarghan Branch, Iran.

PMID: 24592306 PMCID: PMC3938885

Abstract

OBJECTIVE(S): Leptin is a hormone secreted by adipose tissue and is involved not only in the regulation of feeding and energy expenditure, but also its role in memory enhancement has been demonstrated as well. The partial transfer of leptin across the blood-brain barrier in obese individuals causes leptin resistance and prevents leptin reaching brain. On the other hand, studies have shown that angiotensin antagonists such as losartan can improve memory and learning abilities. The aim of this study was to evaluate the effects of losartan on improving memory and leptin resistance induced by high fat diet in obese rats.

MATERIALS AND METHODS: 40 Wistar male rats were divided in 4 groups: control (C), losartan (LOS), high-fat diet (HFD) and high-fat diet and losartan (HFD and LOS). The spatial memory performances of the rats were assessed in the Morris water maze after 2 months of treatment. Then they were weighed and serum levels of leptin and triglyceride were measured.

RESULTS: In spite of receiving high-fat diet, no significant differences in body weight were observed in the (HFD & LOS) group. In the Morris water maze trial, the (LOS) and (HFD & LOS) groups also showed a significant reduction (P <0.05) in latency and path length. In addition, a significant decrease (P <0.05) in serum levels of leptin and no significant difference in serum levels of triglyceride was observed in the (HFD & LOS) group.

CONCLUSION: Losartan can improve leptin resistance induced by obesity and high fat diet. At the same time, it modulates body weight and enhances learning and memory.

Keywords: Learning; Leptin resistance; Losartan; Memory performance; Morris water maze

References

  1. Endocrinology. 2004 Sep;145(9):4103-12 - PubMed
  2. Peptides. 2006 Jun;27(6):1420-5 - PubMed
  3. Neuroreport. 2001 Dec 21;12(18):3947-51 - PubMed
  4. J Clin Endocrinol Metab. 2005 May;90(5):2851-4 - PubMed
  5. Brain Res. 1991 Oct 11;561(2):230-5 - PubMed
  6. Brain Res. 2001 Apr 6;897(1-2):114-21 - PubMed
  7. Neuroreport. 1991 Jun;2(6):351-3 - PubMed
  8. Clin Exp Pharmacol Physiol Suppl. 1996;3:S119-24 - PubMed
  9. J Mol Med (Berl). 2008 Jun;86(6):715-22 - PubMed
  10. Int J Obes Relat Metab Disord. 1993 Jun;17(6):307-15 - PubMed
  11. Curr Opin Pharmacol. 2007 Dec;7(6):643-7 - PubMed
  12. Mol Cell. 1998 Mar;1(4):619-25 - PubMed
  13. Peptides. 2004 Jun;25(6):991-6 - PubMed
  14. Proc Nutr Soc. 1998 Aug;57(3):429-40 - PubMed
  15. Int J Obes Relat Metab Disord. 2003 Feb;27(2):260-8 - PubMed
  16. Diabetes. 2004 May;53(5):1253-60 - PubMed
  17. Biochem Soc Trans. 2005 Nov;33(Pt 5):1029-32 - PubMed
  18. J Cardiovasc Pharmacol. 1992;19 Suppl 6:S80-8 - PubMed
  19. Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E1144-52 - PubMed
  20. J Biol Chem. 2000 Nov 3;275(44):34797-802 - PubMed
  21. Neurobiol Aging. 2001 Jul-Aug;22(4):541-6 - PubMed
  22. J Biol Chem. 2008 Jan 18;283(3):1754-1763 - PubMed
  23. Horm Behav. 2006 Aug;50(2):308-13 - PubMed
  24. Nature. 1993 Jan 7;361(6407):31-9 - PubMed
  25. Science. 1995 Jul 28;269(5223):543-6 - PubMed
  26. J Biol Chem. 2007 Nov 23;282(47):34479-91 - PubMed
  27. Nat Med. 1995 Nov;1(11):1155-61 - PubMed
  28. Dement Geriatr Cogn Disord. 2005;19(2-3):91-6 - PubMed
  29. J Neurochem. 2005 Oct;95(2):396-405 - PubMed
  30. Nature. 1979 Sep 6;281(5726):31-5 - PubMed
  31. JAMA. 1995 Dec 20;274(23):1846-51 - PubMed
  32. Neuroscience. 2006;137(4):1369-79 - PubMed
  33. Acta Neurol Belg. 2009 Sep;109(3):171-80 - PubMed
  34. Brain Res Brain Res Rev. 2001 Aug;36(1):60-90 - PubMed
  35. Behav Brain Res. 2002 Apr 1;131(1-2):79-86 - PubMed
  36. Eur J Pharmacol. 1996 Feb 22;297(3):299-306 - PubMed
  37. BMJ. 1994 Jun 18;308(6944):1604-8 - PubMed
  38. Cell Tissue Res. 2006 Nov;326(2):599-616 - PubMed
  39. Neuropharmacology. 2001 Mar;40(4):618-23 - PubMed
  40. Neuroscience. 2002;113(3):607-15 - PubMed
  41. Circ Res. 2002 Jan 11;90(1):8-10 - PubMed
  42. J Neurosci. 2001 Dec 15;21(24):RC186 - PubMed
  43. Am J Epidemiol. 1993 Sep 15;138(6):353-64 - PubMed
  44. Hypertension. 2003 Mar;41(3 Pt 2):763-7 - PubMed
  45. J Renin Angiotensin Aldosterone Syst. 2002 Sep;3 Suppl 1:S39-48 - PubMed
  46. Psychopharmacology (Berl). 2005 May;179(3):529-35 - PubMed
  47. J Chem Neuroanat. 2000 Dec;20(3-4):339-48 - PubMed
  48. Biochem Biophys Res Commun. 2000 Oct 14;277(1):20-6 - PubMed
  49. N Engl J Med. 1996 Feb 1;334(5):292-5 - PubMed
  50. Peptides. 2006 Nov;27(11):2738-49 - PubMed

Publication Types